Exhibit 10.21  PONIARD PHARMACEUTICALS,
INC.
AMENDED AND RESTATED
KEY EXECUTIVE SEVERANCE AGREEMENT  This Amended and Restated
Key Executive Severance Agreement (this Agreement), dated
as of March 3, 2008, is entered into by and between PONIARD PHARMACEUTICALS,
INC., a Washington corporation (formerly known as NeoRx Corporation and as
supplemented by Section 10, the Company), and RONALD
MARTELL (the Executive).  The Board of Directors of
the Company (the Board) has determined that
it is in the best interests of the Company and its shareholders to ensure that
the Company will have the continued dedication of the Executive,
notwithstanding the fact that the Executive does not have any form of
traditional employment contract or other assurance of job security.  The Board believes it is imperative to
diminish any distraction of the Executive arising from the personal uncertainty
and insecurity that arises in the absence of any assurance of job security by
providing the Executive with reasonable compensation and benefit arrangements
in the event of termination of the Executives employment by the Company under
certain defined circumstances.  In order to accomplish
these objectives, the Board has caused the Company to enter into this
Agreement.  1.Term  The initial term of this Agreement (the Initial
Term) shall be for a period of one (1) year from the date
of thisAgreement as first appearing
above; provided, however, that this Agreement shall automatically renew for
successive additional one (1) year periods (Renewal
Terms), unless notice of nonrenewal is given by either party to
the other party at least nine (9) months prior to the end of the Initial
Term or any Renewal Term, and provided further that if a Change of Control (as
defined in the Change of Control Agreement referenced in Section 16
hereof) occurs during the Term, the Term shall automatically extend for the
duration of the Employment Period (as defined in the Change of Control
Agreement).  The Term
of this Agreement shall be the Initial Term plus all Renewal Terms and, if
applicable, the duration of the Employment Period.  At the end of the Term, this Agreement shall
terminate without further action by either the Company or the Executive.  2.Employment  The Executive and the
Company acknowledge that, except as may otherwise be provided under any other
written agreement between the Executive and the Company, the employment of the
Executive by the Company or by any affiliated or successor company is


at will and may be
terminated by either the Executive or the Company or its affiliated companies
at any time with or without cause, subject to the termination payments
prescribed herein.  3.Attention and Effort  During any period of time
that the Executive remains in the employ of the Company, and excluding any
periods of vacation and sick leave to which the Executive is entitled, the
Executive will devote all of the Executives productive time, ability,
attention and effort to the business and affairs of the Company and the
discharge of the responsibilities assigned to the Executive hereunder, and will
seek to perform faithfully and efficiently such responsibilities.  It shall not be a violation of this Agreement
for the Executive to (a) serve on corporate, civic or charitable boards or
committees, (b) deliver lectures, fulfill speaking engagements or teach at
educational institutions, (c) manage personal investments, or (d) engage
in activities permitted by the policies of the Company or as specifically
permitted by the Company, so long as such activities do not significantly
interfere with the performance of the Executives responsibilities in
accordance with this Agreement.  It is
expressly understood and agreed that to the extent any such activities have
been conducted by the Executive prior to the Term, the continued conduct of
such activities (or the conduct of activities similar in nature and scope
thereto) during the Term shall not thereafter be deemed to interfere with the
performance of the Executives responsibilities to the Company.  4.Termination  During the Term,
employment of the Executive may be terminated as follows, but, in any case, the
nondisclosure provisions set forth in Section 7 hereof shall survive the
termination of this Agreement and the termination of the Executives employment
with the Company:  4.1By the Company or the
Executive  At any time during the
Term, the Company may terminate the employment of the Executive with or without
Cause (as defined below), and the Executive may terminate the Executives employment
for Good Reason (as defined below) or for any reason, upon giving Notice of
Termination (as defined below).  4.2Automatic Termination  This Agreement and the
Executives employment shall terminate automatically upon the death or Total
Disability of the Executive.  The term Total Disability as used herein shall mean the
Executives inability (with such accommodation as may be required by law and
which places no undue burden on the Company), as determined by a physician
selected by the Company and acceptable to the Executive, to perform the
Executives essential duties for a period or periods aggregating twelve (12)
weeks in any three hundred sixty-five (365) day period as a result of physical
or mental illness, loss of legal capacity or any other cause  2


beyond the Executives
control, unless the Executive is granted a leave of absence by the Board.  4.3Notice of Termination  Any termination by the
Company or by the Executive during the Term shall be communicated by Notice of
Termination to the other party given in accordance with Section 9
hereof.  The term Notice
of Termination shall mean a written notice that (a) indicates
the specific termination provision in this Agreement relied upon and (b) to
the extent applicable, sets forth in reasonable detail the facts and
circumstances claimed to provide a basis for termination of the Executives
employment under the provision so indicated. 
The failure by the Executive or the Company to set forth in the Notice
of Termination any fact or circumstance that contributes to a showing of Good
Reason or Cause shall not waive any right of the Executive or the Company
hereunder or preclude the Executive or the Company from asserting such fact or
circumstance in enforcing the Executives or the Companys rights hereunder.  4.4Date of Termination  Date
of Termination means (a) if the Executives employment is
terminated by reason of death, the last day of the calendar month in which the
Executives death occurs, (b) if the Executives employment is terminated
by reason of Total Disability, immediately upon a determination by the
Company of the Executives Total Disability, and (c) in all other cases,
ten (10) days after the date of personal delivery or mailing of the Notice
of Termination.  The Executives
employment and performance of services will continue during such ten (10) day
period; provided, however, that the Company may, upon notice to the Executive
and without reducing the Executives compensation during such period, excuse
the Executive from any or all of the Executives duties during such period.  5.Termination Payments  In the event of
termination of the Executives employment during the Term, all compensation and
benefits shall terminate, except as specifically provided in this Section 5.  5.1Termination by the
Company Other Than for Cause or by the Executive for Good Reason  If during the Term the
Company terminates the Executives employment other than for Cause or the
Executive terminates the Executives employment for Good Reason, the Executive
shall be entitled to:  (a)receive payment of the
following accrued obligations (the Accrued Obligations):  3


(i)the
Executives then current annual base salary through the Date of Termination to
the extent not theretofore paid;  (ii)any
compensation previously deferred by the Executive (together with accrued
interest or earnings thereon, if any); and  (iii)any accrued vacation pay that would be
payable under the Companys standard policy, in each case to the extent not
theretofore paid;  (b)for nine (9) months
after the Date of Termination or until the Executive qualifies for comparable
medical and dental insurance benefits from another employer, whichever occurs
first, the Company shall pay the Executives premiums for health insurance
benefit continuation for the Executive and the Executives family members, if
applicable, that the Company provides to the Executive under the provisions of
the federal Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(COBRA), to the extent that the Company would have paid
such premiums had the Executive remained employed by the Company (such
continued payment is hereinafter referred to as COBRA
Continuation); and  (c)an amount as severance
pay equal to seventy five percent (75%) of the Executives then current annual
base salary for the fiscal year in which the Date of Termination occurs,
subject to payment as set forth in Sections 5.5 and 5.9 hereof.  5.2Termination for Cause or
Other Than for Good Reason  If during the Term the
Executives employment shall be terminated by the Company for Cause or by the
Executive for other than Good Reason, this Agreement shall terminate without
further obligation on the part of the Company to the Executive, other than the
Companys obligation to pay the Executive the Accrued Obligations to the extent
theretofore unpaid.  5.3Expiration of Term  In the event the
Executives employment is not terminated prior to expiration of the Term, this
Agreement shall terminate without further obligation on the part of the Company
to the Executive.  5.4Termination Because of
Death or Total Disability  If the Executives
employment is terminated during the Term by reason of the Executives death or
Total Disability, this Agreement shall terminate automatically without further
obligation on the part of the Company to the Executive or the Executives legal
representatives under this Agreement, other than the Companys obligation to
pay the Executive the Accrued Obligations (which shall be paid to the Executives
estate or  4


beneficiary, as
applicable in the case of the Executives death) and to provide COBRA
Continuation.  5.5Payment Schedule  All payments of Accrued
Obligations, or any portion thereof payable pursuant to this Section 5, other
than deferred compensation pursuant to Section 5.1(a)(ii), shall be made
to the Executive within ten (10) working days of the Date of Termination.  Deferred compensation pursuant to Section 5.1(a)(ii) shall
be payable pursuant to the terms of the deferred compensation program.  Any severance payments payable to the
Executive pursuant to Section 5.1(c) shall be made to the Executive
in the form of salary continuation, payable at normal payroll intervals during
the nine (9) month period following the Date of Termination (Payment Period).  For purposes of determining the payment
schedule, other than for deferred compensation pursuant to Section 5.1(a)(ii),
to the extent that the payment schedule in this Section 5.5 would subject
payments to the distribution requirements set forth in Section 409A(a)(2) of
the Internal Revenue Code of 1986, as amended (Code), because the Date of
Termination is different than the date that a person would be deemed to have
had a separation from service within the meaning of Code Section 409A(a)(2)(i),
the Date of Termination shall be treated as the latest date so as to not
subject such payments to the distribution requirements set forth in Code Section 409A(a)(2).  Notwithstanding the preceding provisions of
this Section 5, if necessary to meet the requirements of subparagraphs (A)(i) and
(B)(i) of Code Section 409A(a)(2), the amounts that would normally be
paid during the first six months after the Executives separation from service
within the meaning of Code Section 409A(a)(2) shall not be paid to an
Executive  who is a specified employee
(as defined in Code Section 409A(a)(2)(B)(i) in accordance with the
procedures established by the Compensation Committee) until the six-month
anniversary of the Executives separation from service.  5.6Cause  For purposes of this
Agreement, Cause means cause given by
the Executive to the Company and shall include, without limitation, the
occurrence of one or more of the following events:  (a)a clear refusal to
carry out any material lawful duties of the Executive or any directions of the
Board or senior management of the Company reasonably consistent with those
duties;  (b)persistent failure to
carry out any lawful duties of the Executive or any directions of the Board or
senior management reasonably consistent with those duties; provided, however,
that the Executive has been given reasonable notice and opportunity to correct
any such failure;  5


(c)violation by the
Executive of a state or federal criminal law involving the commission of a
crime against the Company or any other criminal act involving moral turpitude;  (d)current abuse by the
Executive of alcohol or controlled substances; deception, fraud,
misrepresentation or dishonesty by the Executive; or any incident materially
compromising the Executives reputation or ability to represent the Company
with investors, customers or the public; or  (e)any other material
violation of any provision of this Agreement by the Executive, subject to the
notice and opportunity to cure requirements of Section 8 hereof.  5.7Good Reason  For purposes of this
Agreement, Good Reason means:  (a)reduction of the
Executives annual base salary to a level below the level in effect on the date
of this Agreement, regardless of any change in the Executives duties or
responsibilities;  (b)the assignment to the
Executive of any duties materially inconsistent with the Executives position,
authority, duties or responsibilities or any other action by the Company that
results in a material diminution in such position, authority, duties or
responsibilities, excluding for this purpose an isolated and inadvertent action
not taken in bad faith and that is remedied by the Company promptly after
receipt of notice thereof given by the Executive;  (c)the Companys requiring
the Executive to be based at any office or location more than fifty (50) miles
from the city in which the Executive is currently employed by the Company,
i.e., San Francisco, California or Seattle, Washington;  (d)any failure by the
Company to comply with and satisfy Section 10 hereof, provided, however,
that the Companys successor has received at least ten (10) days prior
written notice from the Company or the Executive of the requirements of Section 10
hereof; or  (e)any other material
violation of any provision of this Agreement by the Company;  provided, however, that
the Executive has notified the Company of such salary reduction, assignment,
failure, situation or violation within ninety (90) days of its occurrence and
there has been compliance with the notice and opportunity to cure requirements
of Section 8 hereof.  6


5.8General Release of
Claims  As a condition to the
payment contemplated by this Section 5, the Executive shall execute a
general release and waiver of claims against the Company in a form satisfactory
to the Company in its sole discretion. 
By way of example and not limitation, the general release and waiver of
claims will include any claims for wages, bonuses, employment benefits, or
damages of any kind whatsoever, arising out of any contracts, express or
implied, any covenant of good faith and fair dealing, express or implied, any
theory of wrongful discharge, any legal restriction on the Companys right to
terminate employment, or any federal, state or other governmental statute or
ordinance, including, without limitation, Title VII of the Civil Rights Act of
1964, the federal Age Discrimination in Employment Act, the Americans with
Disabilities Act, the Family and Medical Leave Act, the Washington Law Against
Discrimination, or any other legal limitation on the employment relationship.  Such release and waiver shall be delivered to
the Company no later than the fifteenth day of the third month of the fiscal
year following the year in which the Date of Termination occurs.  5.9Dispute Regarding Existence
of Good Reason for Termination  In the event the Company
disputes whether Good Reason existed for the Executive to terminate the
Executives employment for Good Reason, the Company shall pay salary
continuation as provided in Section 5.5 until the earliest of (i) settlement
by the parties, (ii) determination by arbitration in accordance with Section 14
hereof that Good Reason did not exist, and (iii) completion of the
payments required by Section 5.5 and Section 5.1(c) hereof.  If, pursuant to Section 14 hereof, an
arbitrator determines that Good Reason did not exist, the arbitrator shall also
decide whether the Executive had a reasonable, good-faith basis for claiming
that there was Good Reason to terminate. 
If the arbitrator determines that there was not such a basis, the Executive
shall be obligated to repay promptly to the Company the salary continuation
payments; if the arbitrator determines that there was such a basis, the
Executive shall not be obligated to repay the salary continuation.  6.Representations, Warranties and Other
Conditions  In order to induce the
Company to enter into this Agreement, the Executive represents and warrants to
the Company as follows:  6.1Health  The Executive is in good
health and knows of no physical or mental disability that, with any accommodation
that may be required by law and that places no undue burden on the Company,
would prevent the Executive from fulfilling the Executives obligations
hereunder.  The Executive agrees, if the
Company requests, to submit to reasonable periodic medical examinations by a
physician or physicians designated, paid for and arranged by the Company.  The Executive agrees that the examinations
medical report shall be provided to the Company.  7


6.2No Violation of Other
Agreements  The Executive represents
that neither the execution nor the performance of this Agreement by the
Executive will violate or conflict in any way with any other agreement or
obligations by which the Executive may be bound.  7.Nondisclosure; Return of Materials  7.1Nondisclosure  Except as required by the
Executives employment with the Company, the Executive will not, at any time
during the term of employment by the Company, or at any time thereafter,
directly, indirectly or otherwise, use, communicate, disclose, disseminate,
lecture upon or publish articles relating to any confidential, proprietary or
trade secret information without the prior written consent of the Company.  The Executive understands that the Company
will be relying on this covenant in continuing the Executives employment,
paying the Executives compensation, granting the Executive any promotions or
raises, or entrusting the Executive with any information that helps the Company
compete with others.  7.2Return of Materials  All documents, records,
notebooks, notes, memoranda, drawings or other documents made or compiled by
the Executive at any time while employed by the Company, or in the Executives possession,
including any and all copies thereof, shall be the property of the Company and
shall be held by the Executive in trust and solely for the benefit of the
Company, and shall be delivered to the Company by the Executive upon
termination of employment or at any other time upon request by the Company.  8.Notice and Cure of Breach  Whenever a breach of this
Agreement by either party is relied upon as justification for any action taken
by the other party pursuant to any provision of this Agreement, other than
clause (a), (b), (c) or (d) of Section 5.6 hereof, before such
action is taken, the party asserting the breach of this Agreement shall give
the other party at least twenty (20) days prior written notice of the
existence and the nature of such breach before taking further action hereunder
and shall give the party purportedly in breach of this Agreement the
opportunity to correct such breach during the twenty (20) day period.  9.Form of Notice  Every notice required by
the terms of this Agreement shall be given in writing by serving the same upon
the party to whom it was addressed personally or by registered or certified
mail, return receipt requested, at the address set forth below or at such other
address as may hereafter be designated by notice given in compliance with the
terms hereof:  8


If to the
  Executive:
  
  Ronald Martell[Address]If to the Company:
  
  Poniard Pharmaceuticals, Inc.300 Elliott Avenue West, Suite 500Seattle, Washington 98119Attn: Chief Executive OfficerWith a copy to:
  
  Perkins Coie LLP1201 Third Avenue, 48th FloorSeattle, Washington 98101-3099Attn: James R. Lisbakken  Except as set forth in Section 4.4
hereof, if notice is mailed, such notice shall be effective upon mailing.  10.Assignment  This Agreement is personal
to the Executive and shall not be assignable by the Executive.  The Company shall assign
to and require any successor (whether direct or indirect, by purchase, merger,
consolidation or otherwise) to all or substantially all the business and/or
assets of the Company to assume expressly and agree to perform this Agreement
in the same manner and to the same extent that the Company would be required to
perform it if no such succession had taken place.  As used in this Agreement, the Company shall mean Poniard Pharmaceuticals, Inc. and
any affiliated company or successor to its business and/or assets as aforesaid
that assumes and agrees to perform this Agreement by contract, operation of law
or otherwise; and as long as such successor assumes and agrees to perform this
Agreement, the termination of the Executives employment by one such entity and
the immediate hiring and continuation of the Executives employment by the
succeeding entity shall not be deemed to constitute a termination or trigger
any severance obligation under this Agreement. 
All the terms and provisions of this Agreement shall be binding upon and
inure to the benefit of and be enforceable by the parties hereto and their
respective successors and permitted assigns.  11.Waivers  No delay or failure by
any party hereto in exercising, protecting or enforcing any of its rights,
titles, interests or remedies hereunder, and no course of dealing or
performance with respect thereto, shall constitute a waiver thereof.  The express waiver by a party hereto of any
right, title, interest or remedy in a particular instance or circumstance shall
not constitute a waiver thereof in any other instance or circumstance.  All rights and remedies shall be cumulative
and not exclusive of any other rights or remedies.  9


12.Amendments
In Writing  No amendment,
modification, waiver, termination or discharge of any provision of this
Agreement, or consent to any departure therefrom by either party hereto, shall
in any event be effective unless the same shall be in writing, specifically
identifying this Agreement and the provision intended to be amended, modified,
waived, terminated or discharged and signed by the Company and the Executive,
and each such amendment, modification, waiver, termination or discharge shall
be effective only in the specific instance and for the specific purpose for
which given.  No provision of this
Agreement shall be varied, contradicted or explained by any oral agreement,
course of dealing or performance or any other matter not set forth in an
agreement in writing and signed by the Company and the Executive.  13.Applicable
Law  This Agreement shall in
all respects, including all matters of construction, validity and performance,
be governed by, and construed and enforced in accordance with, the laws of the
State of Washington, without regard to any rules governing conflicts of
laws.  14.Arbitration;
Attorneys Fees  Except in connection with
enforcing Section 7 hereof, for which legal and equitable remedies may be
sought in a court of law, any dispute arising under this Agreement shall be
subject to arbitration.  The arbitration
proceeding shall be conducted in accordance with the Commercial Arbitration Rules of
the American Arbitration Association (the AAA Rules) then
in effect, conducted by one (1) arbitrator either mutually agreed upon or
selected in accordance with the AAA Rules. 
The arbitration shall be conducted in King County, Washington, under the
jurisdiction of the Seattle office of the American Arbitration
Association.  The arbitrator shall have
authority only to interpret and apply the provisions of this Agreement, and
shall have no authority to add to, subtract from or otherwise modify the terms
of this Agreement.  Any demand for
arbitration must be made within sixty (60) days of the event(s) giving
rise to the claim that this Agreement has been breached.  The arbitrators decision shall be final and
binding, and each party agrees to be bound by the arbitrators award, subject only
to an appeal therefrom in accordance with the laws of the State of
Washington.  Either party may obtain
judgment upon the arbitrators award in the Superior Court of King County,
Washington.  If it becomes necessary
to pursue or defend any legal proceeding, whether in arbitration or court, in
order to resolve a dispute arising under this Agreement, the prevailing party
in any such proceeding shall be entitled to recover its reasonable costs and
attorneys fees.  To the extent necessary
to prevent Executive from being subject to any additional tax pursuant to Code Section 409A(a)(1)(B),
any amounts payable to the Executive pursuant to this paragraph shall be paid
in no event later than the year following the year during which such costs and
fees were incurred.  10


15.Severability  If any provision of this
Agreement shall be held invalid, illegal or unenforceable in any jurisdiction,
for any reason, including, without limitation, the duration of such provision,
its geographical scope or the extent of the activities prohibited or required
by it, then, to the full extent permitted by law, (a) all other provisions
hereof shall remain in full force and effect in such jurisdiction and shall be
liberally construed in order to carry out the intent of the parties hereto as
nearly as may be possible, (b) such invalidity, illegality or
unenforceability shall not affect the validity, legality or enforceability of
any other provision hereof, and (c) any court or arbitrator having
jurisdiction thereover shall have the power to reform such provision to the
extent necessary for such provision to be enforceable under applicable law.  16.Coordination
With Change of Control Agreement  The Company and the
Executive are entering into an Amended and Restated Change of Control Agreement
(the Change of Control Agreement),
which agreement provides for certain forms of severance and benefit payments in
the event of termination of Executives employment under certain defined
circumstances.  This Agreement is in
addition to the Change of Control Agreement, providing certain assurances to
the Executive in circumstances that the Change of Control Agreement does not
cover, and in no way supersedes or nullifies the Change of Control Agreement.  Nevertheless, it is possible that a
termination of employment by the Company or by the Executive may fall within
the scope of both agreements.  In such
event, payments made to the Executive under Section 5.1 hereof shall be
coordinated with payments made to the Executive under Section 8.1 of the
Change of Control Agreement as follows:  (a)Accrued Obligations
under this Agreement need not be paid if paid under the Change of Control
Agreement;  (b)COBRA Continuation
under this Agreement need not be provided if provided under the Change of
Control Agreement; and  (c)the severance payment required under Section 5.1(c) hereof
(and paid pursuant to Section 5.5 hereof) need not be paid to the extent a
severance payment is made under Section 8.1(d) of the Change of
Control Agreement, i.e., the credit from Section 8.1(d) of the Change
of Control Agreement is applied as amounts become due under Section 5.5
hereof.  17.Excess
Parachute Payments  Unless provided by Section 8.8
of the Change of Control Agreement, if any portion of the payments or benefits
under this Agreement or any other agreement or benefit plan of the Company
(including stock options) would be characterized as an excess parachute
payment to the Executive under Section 280G of the Internal Revenue Code
of 1986, as amended (the Code), the Executive shall
be paid any excise tax that the Executive owes under  11


Section 4999 of the
Code as a result of such characterization, such excise tax to be paid to the
Executive at least ten (10) days prior to the date that the Executive is
obligated to make the excise tax payment. 
The determination of whether and to what extent any payments or benefits
would be excess parachute payments and the date by which any excise tax shall
be due, shall be determined in writing by recognized tax counsel selected by
the Company and reasonably acceptable to the Executive.  Without limitation on the foregoing, the
payments made pursuant to this Section 17 shall be made no later than the
end of the year following the year in which the Executive remits such excise
tax to the IRS.  18.Entire
Agreement  This Agreement supersedes
and replaces the Key Executive Severance Agreement, dated as of May 7,
2007, between the parties, and except as described in Section 16 hereof,
this Agreement constitutes the entire agreement between the Company and the
Executive with respect to the subject matter hereof, and all prior or
contemporaneous oral or written communications, understandings or agreements
between the Company and the Executive with respect to such subject matter, are
hereby superseded and nullified in their entireties, except that the
Proprietary Information and Invention Agreement between the Executive and the
Company shall continue in full force and effect to the extent not superseded by
Section 10 hereof.  19.Withholding  The Company may
withhold from any amounts payable under this Agreement such federal, state or
local taxes as shall be required to be withheld pursuant to any applicable law
or regulation.  20.409A
Interpretation Provision  The
Company intends that this Agreement fully comply with the payout and other
limitations and restrictions imposed under Code Section 409A if and to the
extent such Code Section 409A is otherwise applicable to payments under
this Agreement and such compliance is necessary to avoid the penalties
otherwise imposed under Code Section 409A. In this connection, the Company
and Executive agree that the payout timing provisions and any other terms of
this Agreement shall be interpreted and deemed modified, if and to the extent
necessary, to comply with the payout and other limitations and restrictions
imposed under Code Section 409A if and to the extent such Code Section 409A
is otherwise applicable to this Agreement and such compliance is necessary to
avoid the penalties otherwise imposed under Code Section 409A.  21.Counterparts  This Agreement may be
executed in counterparts, each of which counterpart shall be deemed an
original, but all of which together shall constitute one and the same
instrument.  12


IN WITNESS WHEREOF, the parties have executed and
entered into this Agreement effective on the date first set forth above.  PONIARD
  PHARMACEUTICALS, INC.By:
  /s/ Caroline
  LoewyName: Caroline
  LoewyIts: Chief
  Financial OfficerEXECUTIVEBy:
  /s/ Ronald
  MartellName: Ronald
  Martell  13